Epiminder (ASX: EPI) made its ASX debut on Monday after raising $125 million at $1.50 per share, giving the company a market capitalisation of approximately $325 million. The Melbourne-based medtech…
After two slow years marked by rising interest rates and cautious markets, 2025 looks set to be a turning point for ASX IPOs. However, this isn’t simply a broad rebound.…
Australia’s IPO market is approaching a potential turning point, as recent economic data indicates a likely shift in monetary policy. With inflation trending lower and the Reserve Bank of Australia…